(Q37960953)

26 August 2017

0 references

Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis (English)

1 reference

26 August 2017

0 references

Prader–Willi syndrome

1 reference

2

Anne Klibanski

1 reference

26 August 2017

Ruth Sanchez-Ortiga

1

1 reference

PubMed ID

22117629

26 August 2017

Nicholas A Tritos

series ordinal

3

1 reference

26 August 2017

1 July 2012

1 reference

26 August 2017

Clinical Endocrinology

1 reference

26 August 2017

77

1 reference

26 August 2017

1

1 reference

26 August 2017

86-93

1 reference

Recommendations for the diagnosis and management of Prader-Willi syndrome

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Sleep and breathing in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Growth hormone treatment improves body composition in adults with Prader–Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Somatropin therapy in adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04303.X

10.1111/J.1365-2265.2011.04303.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22117629